Source: Lung Science Conference 2015



Rating:

Share or cite this content

Citations should be made in the following way:
G. Nunez (Ann Arbor, United States of America). The inflammasome in health and disease. Lung Science Conference 2015

Member's Comments

No comment yet.

Related content which might interest you: The activation of NLRP3 inflammasome pathway in COPD is limited in local airways Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Activation of the inflammasome pathway during exacerbations of COPD Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease Source: Eur Respir Rev, 27 (148) 180017; 10.1183/16000617.0017-2018 Year: 2018 Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 The NLRP3 inflammasome in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 The growing chronic disease burden in Europe: a role for respiratory health professionals? Source: Eur Respir J 2014; 43: 1249-1251 Year: 2014 A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease. Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Integration of care pathways for HIV-tuberculosis coinfection: a public health agenda Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Getting better data to measure the burden of respiratory disease and influence health and public health policy Source: Annual Congress 2012 - The global burden of disease Year: 2012 The inflammasome pathway in stable COPD and acute exacerbations Source: ERJ Open Res 2016: 00002-2016 Year: 2016 Autophagy and the inflammasome Source: Annual Congress 2013 –Inflammasomes in lung diseases Year: 2013 Mitochondria in health, aging and disease Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease Year: 2019 Late Breaking Abstract - The pro-inflammatory activity and role of NLRP3 inflammasome in severe influenza A virus pneumonia. Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond Year: 2021